Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus

Authors

Atefeh Yas, Faculty of Nursing and Midwifery, Mashhad University of Medical Science, Mashhad, Iran
Fatemeh Z. Karimi, Nursing and Midwifery Care Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Talat Khadivzadeh, Nursing and Midwifery Care Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Publication Date

8-29-2024

First Page

418

Last Page

419

Creative Commons License

This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 International License.

Recommended Citation

Yas, Atefeh; Karimi, Fatemeh Z.; and Khadivzadeh, Talat (2024) "Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus," Sultan Qaboos University Medical Journal: Vol. 24: 418-419.
DOI: https://doi.org/10.18295/squmj.12.2023.092